Virtual Pharma: Supplying the Future with Medicine
CRO Solutions, Inc. announced the launch of VxP Pharma, Inc.- a wholly owned subsidiary of CRO Solutions, Inc. VxP Pharma is comprised of the combined services of the independently owned and operated "niche" CROs of parent company - CRO Solutions, Inc. VxP Pharma offers pharmaceutical development services, as well as technical support, for the development and production of pharmaceuticals, diagnostics, and drug/device combination products from Discovery through Phase IIb. We can help you navigate complex development problems, as well as regulatory hurdles. When you work with VxP, you will collaborate directly with dedicated experts in each area of development, and not simply a “generalist” who happens to be assigned to your project.
VxP Pharma CEO - Raymond E Peck says "Pharmaceutical and biotech research scientists throughout the industry tell us that they prefer to work with smaller, focused, Contract Research Organizations (CROs), rather than with the huge multinational 'one-size-fits-all' CROs. For these people, VxP Pharma is a perfect fit because we offer a single point of contact, as well as the confidence that, if you work with VxP, you are working with a state-of-the-art lab that has been subject to a complete audit, including, in most cases, an audit by the US FDA. Because VxP consists of smaller, independently owned and operated facilities who focus on only one area of drug development, our drug development clients get all the advantages of working directly with a specialist "niche" CRO, including being able to work with some of the best subject matter experts in the industry."
VxP Pharma Services offers the convenience of a central “One Stop Shop” CRO, combined with the advantages of working with a specialist “Niche CRO.” We’re able to deliver this unique capability because each facility is independently owned and operated, and specialize in only one area of development. The Solid State Chemistry lab only performs solid state chemistry, and the preclinical facility performs only services needed during preclinical development. Because they focus on their core competencies, the subject matter experts at each of the locations are among the world’s best.
Although most operations are located in the United States, some facilities are located in Europe and Asia. The majority of these sites have been US-FDA audited, and all have a long track record of successful collaborations with global pharma clients, virtual companies, and everything in between. Whether you’re an entrepreneur at a small virtual company who wears many development hats, or a specialist at a large pharma company, VxP can deliver the services and the solutions that you need to get your molecule into the clinic, and on the fast track to market.
VxP Pharma Services provides solid oral dosage product development, scale–up and commercial manufacturing services as well as sterile fill finish capabilities to the global pharmaceutical market. We have the capabilities and resources to implement many new and advanced technologies to your commercial program, as well as the facilities and equipment to meet the high volume requirements of our clients.Compliant with Title 21 CFR part 11, all data is inspected and quality audited to ensure full cGMP manufacturing compliance, accountability and document traceability. Whether it is dosage aesthetics, special packaging requirements, or fast-track timelines, VxP Pharma will communicate with you throughout the entire program to meet and exceed your expectations.
VxP is also an active participant in a wide variety of industry events in the United States and internationally. If you’ll be attending any of the major trade show events this year, please look us up. We’d love to discuss how VxP can help with your pharmaceutical development needs.